This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Dharmika Lansakara-P: Innovator in Nucleobase Analogue Derivatives
Introduction
Dharmika Lansakara-P is an accomplished inventor based in Austin, TX (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of nucleobase analogue derivatives. His work focuses on creating compounds that have the potential to treat various types of cancer.
Latest Patents
Lansakara-P holds a patent for "Nucleobase analogue derivatives and their applications." This patent discloses derivatives of nucleobase analogues that include a nucleobase moiety and an omega-3 polyunsaturated fatty acid moiety. The compounds also encompass pharmaceutically acceptable salts or prodrugs. Notably, the methods of using these compounds for the treatment of cancers, including pancreatic cancer, are also detailed in the patent. He has 1 patent to his name.
Career Highlights
Dharmika Lansakara-P is affiliated with the University of Texas System, where he continues to advance research in his field. His innovative approach to drug development has garnered attention and respect within the scientific community.
Collaborations
One of his notable collaborators is Zhengrong Cui, who is also a prominent figure in the research community. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.
Conclusion
Dharmika Lansakara-P is a notable inventor whose work on nucleobase analogue derivatives holds promise for cancer treatment. His contributions to the field are significant and reflect his dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
